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INTRODUCTION
Rhabdoid tumor was originally described in 1978 by Beck-
with et al. (1) as a highly malignant pediatric tumor of the
kidney, and Rorke et al. (2) named primary central nervous
system malignant rhabdoid tumor as ‘atypical teratoid/rhab-
doid tumor (ATT/RhT)’. These tumors resemble rhabdomy-
osarcomas, but their immunohistochemical and ultrastruc-
tural features allow a clear distinction between the two types
of tumors. Recently, some authors have reported a small num-
ber of cases of extrarenal rhabdoid tumors. Primary central
nervous system (CNS) malignant rhabdoid tumors are rare.
Since 1985, 85 cases of primary CNS malignant rhabdoid
tumor have been documented (2-6). Intracranial ATT/RhT
is a disease of infancy and childhood, usually occurring dur-
ing the first decade of life (2). The most common biological-
ly malignant CNS tumor in this period is a primitive neu-
roectodermal tumor-medulloblastoma (PNET-MB). ATT/
RhT has been frequently misdiagnosed as a PNET-MB be-
cause 70% of ATT/RhTs contain histological fields indistin-
guishable from classic PNET-MB. However, microscopic
features in routine and special studies allow the differential
diagnosis of PNET-MB and ATT/RhT (1-6). We report a
case of a primary CNS ATT/RhT arising from the posterior
cranial fossa in a child. The clinical course of the patient is
described with a special emphasis on the differential diagno-
sis between ATT/RhT and PNET-MB. 
CASE REPORT
A 16-month-old baby boy had been suffering from vom-
iting and progressive gait disturbance since the age of 14
months. He was irritable, drowsy, and showed bilateral pa-
pilledema and bilateral Babinski’s sign on admission.
Computerized tomography (CT) showed a 4×4 cm-sized
tumor with calcification in the posterior cranial fossa. The
mass revealed heterogeneous density on the pre-contrast CT
and heterogeneous enhancement with contrast infusion (Fig.
1). Subsequent magnetic resonance imaging (MRI) demon-
strated a mass occupying the fourth ventricle and compress-
ing the right posterior aspect of the brainstem (Fig. 2).
With a preoperative diagnosis of PNET-MB, surgery was
performed via a median suboccipital craniotomy, and the ce-
rebellar vermian incision. The mass, which originated from
the fourth ventricle invading both cerebellar hemisphere and
brainstem, was grayish, friable and highly vascular. Subtotal
removal of the tumor was performed leaving a small portion
of the tumor which was tightly adhered to the ventricular
floor.
Histopathological findings depicted the aggregation of
large, pale, and polygonal cells with distinct cell borders, ve-
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Primary Intracranial Atypical Teratoid/Rhabdoid Tumor in a Child
: A Case Report
Rhabdoid tumors of the central nervous system are rare malignancies. Primary
central nervous system atypical teratoid/rhabdoid tumors (ATT/RhTs) mostly occur
during early childhood and are almost invariably fatal. These tumors show similar
histological and radiological features to primitive neuroectodermal tumor-medul-
loblastoma (PNET-MB) but have different biological behaviors. We report a case
of primary intracranial ATT/RhT in the posterior cranial fossa of a child. Preoper-
ative radiological diagnosis was PNET-MB, but pathological diagnosis is ATT/
RhT. The case involved a 16-month-old baby boy who presented with severe
headache, vomiting, and gait disturbance. He was treated by surgical resection,
chemotherapy, and radiotherapy. Despite aggressive therapy, he died 19 months
after diagnosis. Clinical, radiological, and histopathological features of primary
intracranial ATT/RhT are discussed with a special emphasis on the differential
diagnosis from PNET-MB.
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sicular nuclei, occasional single prominent nucleolus, and
moderate amounts of eosinophilic or pale cytoplasm (Fig. 3A).
In addition to these rhabdoid cells, some cells with intracy-
toplasmic hyaline-like eosinophilic material were found. The
material was displacing the nuclei to the eccentric side, and
creating the classic ‘rhabdoid’ appearance, as seen in the rhab-
doid tumor of the kidney. Portions consisting of small undif-
ferentiated cells with indistinct cell borders resembling me-
dulloblastoma were also found. Immunohistochemical study
revealed both large and small cells which were focally posi-
tive for cytokeratin (Fig. 3B), epithelial membrane antigen
(EMA, Fig. 3C), synaptophysin, and vimentin (Fig. 3D).
They were totally negative for glial fibrillary acidic protein
(GFAP). These histologic and immunohistochemical find-
ings were compatible with a diagnosis of ATT/RhT.
After surgical removal of the tumor, the patient received
four cycles of chemotherapy according to the eight-drugs-in-
one-day protocol. A small enhancing nodule was detected on
the left cerebellum on brain MRI after the second chemother-
apy. Subsequent spinal MRI showed linearly enhancing le-
sions along the surface of the spinal cord, suggesting an in-
traspinal dissemination. Radiotherapy was given with a total
intracranial dose of 4,860 cGy in 27 fractions and a total spinal
dose of 2,400 cGy in 16 fractions. Though he received two
additional cycles of chemotherapy, the tumor volume was not
reduced. He died 19 months after the diagnosis. Autopsy was
not performed.
DISCUSSION
ATT/RhT is a tumor of infancy and childhood, and very
rare in adults (5, 6, 9). The mean age of the patients is 2.9 yr
and three-quarters of them are 3 yr or younger at the time of
diagnosis with a male predominance (10). Childhood PNET-
MB, tends to appear between 3 and 5 yr of age. Eighty per-
cent of classic PNET-MBs arise in the cerebellum, but the
ATT/RhTs develop on that site in only slightly over half (3-
Fig. 1. The computerized tomography showed a 4×4 cm-sized
tumor in the posterior cranial fossa with calcification and strong
enhancement.
Fig. 2. Magnetic resonance imaging demonstrated a mass occupying the fourth ventricle compressing the right posterior aspect of the
brainstem. axial image (A), sagittal image (B).
A B6, 10). The cerebellopontine angle appears to be a common
location for ATT/RhT; 15% in series of Rorke et al. (6). ATT/
RhT is a highly malignant neoplasm involving leptomeningeal
dissemination in 10-30% of patients (3-6, 10).
Clinical presentation depends on the age of onset and the
location of the tumor. Children younger than 3 yr of age usu-
ally present with nonspecific symptoms and signs, such as
vomiting, lethargy, irritability, loss of weight, macrocephaly,
and failure to thrive. Older patients commonly present with
increased intracranial pressure or localizing signs. Cranial
nerve palsies, headache, and hemiplegia are common (2-4, 6). 
Many authors have reported that the clinical symptoms
and signs, and the radiological appearance of ATT/RhT are
similar to those of PNET-MB, which frequently misleads
ATT/RhT to a preoperative diagnosis of PNET/MB. The
characteristic findings of ATT/RhT are heterogeneous den-
sity on pre-contrast CT, and inhomogeneous enhancement.
Calcification, cyst formation, and hemorrhage are frequent-
ly associated. On MRI, ATT/RhT usually shows a decreased
signal intensity on T2-weighted images, an isosignal inten-
sity on proton image, and inhomogeneous enhancement with
gadolinium. Differential diagnosis between ATT/RhT and
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Fig. 3. Photomicrography of the tumor discloses aggregations of large, pale, polygonal cells with vesicular nuclei, occasional single
prominent nucleolus, and moderate amount of eosinophilic cytoplasm (H&E, A). Immunohistochemical stains for cytokeratin (B), epithe-
lial membrane antigen (C), and vimentin (D) reveal focal positive reactions (A-D, original magnification×200).
A B
C DPNET-MB is difficult by radiological findings, but is easier
by histopathological findings (6). The malignant rhabdoid
tumors are mainly composed of rhabdoid cells, but they also
contain areas of primitive neuroectodermal cells with both
epithelial and mesenchymal components, which explains
why these tumors have been misdiagnosed as PNET-MB in
the past. This variety of histological components in the malig-
nant rhabdoid tumor suggests that this tumor is a special
type of teratoma, and this motivated Rorke et al. to propose
the name ‘atypical teratoid/rhabdoid tumor’ for the malignant
form of rhabdoid tumor (5). Light microscopic examination
of ATT/RhT reveals a diffuse growth pattern of predominant-
ly polygonal cells arranged in a focally trabecular or alveolar
fashion, cells with vesicular nuclei and prominent nucleoli,
and scattered cells with globular hyaline cytoplasmic inclu-
sions in the vicinity of the nuclei. Electron microscopy shows
whorls of filaments in the cytoplasm, which can be classified
as intermediate filaments and represent vimentin (1, 2, 5, 6).
Results of the immunohistochemical studies show positivi-
ties for three antibodies whose epitopes are almost always ex-
pressed: EMA, vimentin, and smooth-muscle actin (SMA)
(3, 4, 6, 7, 10). These positivities are not found in PNET-
MBs: in particular, EMA is always negative in PNET-MBs
(10). Results for GFAP, germ cell tumor markers, desmin,
neurofilament, and myoglobulin are negative (2, 4-6, 10).
Some authors have described deletion or monosomy of chro-
mosome 22 as the most common abnormality in the CNS
ATT/RhT (5, 6, 8). Differential diagnosis must include PN
ET-MB, ependymoma, choroid plexus papilloma, and tera-
toma. 
There has hitherto been no satisfactory treatment for ATT/
RhT. The majority of patients die within the first year of local
tumor relapse or of leptomeningeal dissemination (2, 4, 5).
ATT/RhT is frequently disseminated along the neuraxis at
the time of disease relapse. The purpose of surgery is to make
a diagnosis and to reduce the tumor burden. Children with
ATT/RhT rarely respond to treatment despite the use of ag-
gressive chemotherapy and/or radiotherapy (6).
The median time to tumor progression is 4.5 months, and
the mean survival duration is 6 months (6). Survival is poor
and unrelated to the age of the patient at the time of diagno-
sis, the extent of resection, or the type of adjuvant postoper-
ative therapy.
In summary, we reported a case of a 16-month-old male
who presented with vomiting, lethargy, and gait disturbance.
Preoperative CT and MRI seemed to indicate PNET-MB.
Total tumor removal was not possible owing to the invasion
of the brainstem. The pathological findings of the resected
tissue were consistent with ATT/RhT. CNS ATT/RhT is very
rare, and its prognosis is invariably poor according to the pre-
vious reports. Considerations on ATT/RhT in the differen-
tial diagnosis of posterior cranial fossa tumors may help to
avoid misdiagnosis and erroneous prognostication.
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